Novo Nordisk A S
Close on Nov 20, 2026Market cap $168.87BP/E 11.1Yield –
Novo Nordisk A S Parent Company by Year
Parent Company — Contract manufacturer (CMO) purchase obligations (DKKm)
Novo Nordisk A S Parent Company: 91,031.00 DKKm in FY2025, up 28.1% from a year earlier.
Where the FY2025 figure comes from
“|| Purchase obligation relating to contract manufacturers | 91,031 | 71,061”
Source: Form 20-F (filed 2026-02-04) ↗
Reported in Novo Nordisk Annual Report — Financial Statements of the Parent Company (Note 15).
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Parent Company — Contract manufacturer (CMO) purchase obligations (DKKm) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 91,031.00 | +28.1% | Form 20-F (filed 2026-02-04) ↗ |
| FY2024 | Dec 31, 2024 | 71,061.00 | +114.6% | Form 20-F (filed 2026-02-04) ↗ |
| FY2023 | Dec 31, 2023 | 33,107.00 | – | Form 20-F (filed 2025-02-05) ↗ |
Breakdown
What makes up parent Company
Cite this data
StockData. (2026). Novo Nordisk A S Parent Company, annual FY2023–FY2025 [Data set]. Compiled from Novo Nordisk A S SEC filings and investor materials. https://stockdatahq.com/stocks/nvo/kpis/parent-comm-cmo
See every metric in the Novo Nordisk A S KPI table. Data updated Nov 3, 2026.
See a number that looks wrong?